🇺🇸 FDA
Patent

US 9452221

Poly(acrylate) polymers for in vivo nucleic acid delivery

granted A61KA61K47/32A61K47/58

Quick answer

US patent 9452221 (Poly(acrylate) polymers for in vivo nucleic acid delivery) held by Arrowhead Pharmaceuticals, Inc. expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Pharmaceuticals, Inc.
Grant date
Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K47/32, A61K47/58, A61P, A61P43/00